Subpart A

General Provisions

310.3Definitions and interpretations.310.4Biologics; products subject to license control.310.6Applicability of “new drug” or safety or effectiveness findings in drug efficacy study implementation notices and notices of opportunity for hearing to identical, related, and similar drug products.